These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8199099)

  • 1. Advanced endoscopic techniques used in dysfunctional bleeding, fibroids and endometriosis, and the role of gonadotrophin-releasing hormone agonist treatment.
    Donnez J; Nisolle M; Clerckx F; Casanas-Roux F; Saussoy P; Gillerot S
    Br J Obstet Gynaecol; 1994 May; 101 Suppl 10():2-9. PubMed ID: 8199099
    [No Abstract]   [Full Text] [Related]  

  • 2. Expansive benign lesions: treatment by laser.
    Smets M; Nisolle M; Bassil S; Donnez J
    Eur J Obstet Gynecol Reprod Biol; 1996 Mar; 65(1):101-5. PubMed ID: 8706940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of goserelin and danazol as endometrial thinning agents prior to endometrial laser ablation.
    Garry R; Khair A; Mooney P; Stuart M
    Br J Obstet Gynaecol; 1996 Apr; 103(4):339-44. PubMed ID: 8605131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-operative endometrial thinning agents before hysteroscopic surgery for heavy menstrual bleeding.
    Sowter MC; Singla AA; Lethaby A
    Cochrane Database Syst Rev; 2000; (2):CD001124. PubMed ID: 10796747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The efficacy of the hysteroscopic treatment of menorrhagia associated with uterine fibromyomas].
    Pellicano M; Vigorito R; Magri G; Castellano A
    Minerva Ginecol; 1994 Oct; 46(10):545-9. PubMed ID: 7838410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WITHDRAWN: Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.
    Sowter MC; Lethaby A; Singla AA
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD001124. PubMed ID: 25070909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal uterine bleeding: surgical management--part III.
    Munro MG
    J Am Assoc Gynecol Laparosc; 2001 Feb; 8(1):18-44, test 45-7. PubMed ID: 11274617
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of dysfunctional bleeding and fibroids by advanced endoscopic techniques with the Nd:YAG laser: from the present to the future.
    Donnez J; Polet R; Anaf V; Mathieu PE; Casanas-Roux F; Nisolle M
    Baillieres Clin Obstet Gynaecol; 1995 Jun; 9(2):329-45. PubMed ID: 7554616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial Nd-YAG laser ablation by hysterofibroscopy: long-term results of 137 cases.
    Jourdain O; Joyeux P; Lajus C; Sfaxi I; Harle T; Roux D; Dallay D
    Eur J Obstet Gynecol Reprod Biol; 1996 Nov; 69(2):103-7. PubMed ID: 8902441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of menorrhagia.
    Wood C
    Aust Fam Physician; 1995 May; 24(5):825, 828-32. PubMed ID: 7794145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thinning the endometrium prior to ablation: is it worthwhile?
    Sutton CJ; Ewen SP
    Br J Obstet Gynaecol; 1994 May; 101 Suppl 10():10-2. PubMed ID: 8199096
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment with the gonadotrophin releasing hormone-agonist goserelin before hysterectomy for uterine fibroids.
    Lumsden MA; West CP; Thomas E; Coutts J; Hillier H; Thomas N; Baird DT
    Br J Obstet Gynaecol; 1994 May; 101(5):438-42. PubMed ID: 8018618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotropin releasing hormone agonist treatment before hysteroscopic endometrial resection.
    Vercellini P; Trespidi L; Bramante T; Panazza S; Mauro F; Crosignani PG
    Int J Gynaecol Obstet; 1994 Jun; 45(3):235-9. PubMed ID: 7926242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transcervical resection of endometrium and myomas in women with bleeding disorders].
    Istre O
    Tidsskr Nor Laegeforen; 1991 Apr; 111(10):1213-6. PubMed ID: 2042126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does preoperative treatment with a gonadotropin-releasing hormone agonist improve the outcome of endometrial resection?
    Vercellin P; Perin A; Consonn R; Oldan S; Parazzini F; Crosignani PG
    J Am Assoc Gynecol Laparosc; 1998 Nov; 5(4):357-60. PubMed ID: 9782138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.
    Tan YH; Lethaby A
    Cochrane Database Syst Rev; 2013 Nov; (11):CD010241. PubMed ID: 24234875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgical hysteroscopy or hysterectomy in the treatment of benign uterine lesions. What to choose in 1998?].
    Herman P; Gaspard U; Foidart JM
    Rev Med Liege; 1998 Dec; 53(12):756-61. PubMed ID: 9927874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadotropin releasing hormone agonist treatment before hysterectomy for menorrhagia and uterine leiomyomas.
    Vercellini P; Bocciolone L; Colombo A; Vendola N; Meschia M; Bolis G
    Acta Obstet Gynecol Scand; 1993 Jul; 72(5):369-73. PubMed ID: 8392268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depot goserelin and danazol pre-treatment before rollerball endometrial ablation for menorrhagia.
    Fraser IS; Healy DL; Torode H; Song JY; Mamers P; Wilde F
    Obstet Gynecol; 1996 Apr; 87(4):544-50. PubMed ID: 8602306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hysteroscopic treatment of menorrhagia associated with uterine leiomyomas.
    Indman PD
    Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):716-20. PubMed ID: 8469459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.